LONDON, UK. March 24th, 2026 – Professor Martin Whyte, a Consultant Physician and Associate Professor of Metabolic Medicine, has announced that private patients now have direct access to the most recent advancements in Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD) management through his clinic.
As a Professor at the University of Surrey and a Consultant at King’s College Hospital, Professor Whyte occupies a rare position where academic research meets daily clinical practice. This dual role allows him to implement sophisticated treatments and pharmacological developments, such as the latest GLP-1 analogues and SGLT2 inhibitors, at a pace much faster than the capabilities of standard clinics where such advancements can take years.
Metabolic health is not a singular metric but a complex system of interactions between the liver, pancreas, and cellular insulin sensitivity. Professor Whyte’s approach moves beyond the simple management of blood glucose levels to address the underlying physiological triggers of metabolic dysfunction.
By focusing on the specific mechanisms of insulin resistance, he creates clinical pathways that are highly specific to the individual biology of the patient. This extensive body of work in metabolic medicine ensures that every treatment plan is grounded in the latest global data.
“A diagnosis of Type 2 Diabetes or NAFLD is often a sign of a system in distress, not just a high blood sugar reading,” Professor Martin Whyte said.
“The goal is to identify exactly where the metabolic break has occurred. Whether the issue is primarily liver fat accumulation or a decline in insulin production, the strategy must be tailored. When we apply the latest research directly to patient care, we see much more effective outcomes, including the potential for disease remission.”
Professor Whyte’s clinical decisions are underpinned by a significant academic career, including a PhD focused on insulin action and a portfolio of over 100 published research articles.
Recognised as a Key Opinion Leader (KOL) within the medical community, Professor Whyte is frequently consulted for his expertise on the metabolic consequences of obesity and cardiovascular health. His private consultations offer an environment where patients can discuss the complexities of their health with a specialist who is actively shaping the future of metabolic medicine. From intensive weight management to the reversal of fatty liver disease, the focus remains on using evidence-based science to achieve long-term health recovery.
For those seeking a specialist who combines high-level academic insight with practical, compassionate care, Professor Whyte provides a bridge to the next generation of metabolic treatments.
For more details visit www.drmartinwhyte.com.
ENDS